Last month, the European Commission announced the non-approval of 14 active substance/product type combinations. These combinations must be phased off the European market. Importantly, this also applies to the Northern Irish market. The official announcement can be found here. Regulation (EU) No 528/2012 of the European Parliament and of the Council (BPR) requires all activeContinue reading “Stocks of relevant products must be fully removed from supply chains on the Northern Irish market due to the latest active substance list update – will your inventory be impacted?”